End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
30.9 CNY | -6.08% | -6.70% | -25.07% |
05-10 | China Grants Clinical Trial Approval to Bio-Thera's Anti-Tumor Combination Therapy | MT |
04-29 | Bio-Thera Solutions, Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Neutral | Neutral | Neutral |
Resistance | 37.00 | 44.99 | 44.42 |
Spread/Res. | -16.49% | -31.32% | -30.44% |
Spread/Supp. | +8.84% | +19.72% | +20.66% |
Support | 28.39 | 25.81 | 25.61 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- 688177 Stock
- Charts Bio-Thera Solutions, Ltd.